financetom
Business
financetom
/
Business
/
STMicroelectronics' supervisory board denies allegations of insider trading
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
STMicroelectronics' supervisory board denies allegations of insider trading
Apr 10, 2025 1:19 AM

(Reuters) -STMicroelectronics' supervisory board on Thursday denied allegations of insider trading concerning two members of the chipmaker's managing board.

The statement came a day after Italy's economy minister Giancarlo Giorgetti accused STMicro's management of having sold shares it held a day before reporting negative results.

"Stock sales done during company's blackout period were made by company's stock plan administrator, through an automatic procedure," STMicro said in the statement.

Giorgetti also said the Italian government opposes STMicro's CEO Jean-Marc Chery. The Italian and French governments own a combined 27.5% share in STMicro through a holding company.

European chipmakers, including STMicro, are facing a downturn in their strongholds of automotive and industrial markets.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alphabet's Google Engaged in Anti-Competitive Practices in Open-Display Ad Tech, UK Regulator Says
Alphabet's Google Engaged in Anti-Competitive Practices in Open-Display Ad Tech, UK Regulator Says
Sep 6, 2024
07:45 AM EDT, 09/06/2024 (MT Newswires) -- Alphabet's (GOOG) Google ( GOOG ) has been engaging in anti-competitive practices in the open-display advertising technology sector that potentially could be harming thousands of UK publishers and advertisers, the UK Competition and Markets Authority, or CMA, said Friday, citing provisional findings of an investigation. The CMA's investigation focuses on Google's ( GOOG...
Vor Biopharma Reports Positive Trem-Cell Study Data; Shares Rise
Vor Biopharma Reports Positive Trem-Cell Study Data; Shares Rise
Sep 6, 2024
07:47 AM EDT, 09/06/2024 (MT Newswires) -- Vor Biopharma ( VOR ) said Thursday that new clinical data from its ongoing phase 1/2 study of patients with relapsed or refractory acute myeloid leukemia treated with trem-cel followed by Mylotarg validated its approach of using shielded transplants in delivering targeted therapies. The data showed reliable engraftment, shielding of the blood system...
Axogen Submits Biologics License Application to US FDA for Avance Nerve Graft
Axogen Submits Biologics License Application to US FDA for Avance Nerve Graft
Sep 6, 2024
07:46 AM EDT, 09/06/2024 (MT Newswires) -- Axogen ( AXGN ) said Friday that it has completed the rolling submission process for a biologics license application for Avance Nerve Graft to the US Food and Drug Administration. The company said it expects to be notified within the next 60 days on whether the application has been accepted for review. Axogen...
Top Premarket Decliners
Top Premarket Decliners
Sep 6, 2024
07:56 AM EDT, 09/06/2024 (MT Newswires) -- Eastside Distilling ( EAST ) shares slumped 20% pre-bell Friday, paring Thursday's rally. Fonar Corporation ( FONR ) shares fell nearly 24% following a 1.5% loss in the previous session. Clene ( CLNN ) shares retreated 7%, adding to Thursday's 5.3% drop. Harte Hanks ( HHS ) shares were down 12% following a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved